Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01150188 · ClinicalTrials.gov registry record · NA
Effects of Amino Acids on Regional Lipid Metabolism
A NA study of Hypertriglyceridemia, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT01150188: Completed NA study of Hypertriglyceridemia, sponsored by University of Arkansas.
NCT01150188 is a NA study of Hypertriglyceridemia that has completed, run by University of Arkansas. The registered enrollment target is 125 participants, below the 171-participant average among 25 other Hypertriglyceridemia trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01150188, a NA study of Hypertriglyceridemia, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Elevated fat level in blood is a risk factor for coronary heart disease, a major cause of death in America. The overall goal of this project is to test a novel treatment using nutrient (amino acid) supplementation against this condition in men and women, and to understand how this treatment works.
Primary Outcome
Turnover rates of VLDL-triglycerides and VLDL-ApoB-100, including synthesis and breakdown rates, measured before and after eight weeks of amino acid supplementation
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Amino acids
Study Locations (1)
Arkansas
- University of Arkansas for Medical Science, Reynolds Aging Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2010-06 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT01150188 record still lists
NCT01150188 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 171-participant average among 25 other Hypertriglyceridemia trials with a reported enrollment target (27% lower).
The record links to 1 condition, with Hypertriglyceridemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01150188 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT01150188 about?
NCT01150188 is a clinical study titled "Effects of Amino Acids on Regional Lipid Metabolism". Elevated fat level in blood is a risk factor for coronary heart disease, a major cause of death in America. The overall goal of this project is to test a novel treatment using nutrient (amino acid) supplementation against this condition in men and women, and to understand how this treatment works.
What is the current status of trial NCT01150188?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2010-06. Estimated completion is 2016-08.
What conditions does trial NCT01150188 study?
This clinical trial studies the following conditions: Hypertriglyceridemia.
What interventions are being tested in trial NCT01150188?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Amino acids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01150188?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01150188 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertriglyceridemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01150188's enrollment target sits among peer trials
125 6th of 25 higher than 20 of 25 other Hypertriglyceridemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertriglyceridemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Diet Interventions on Monocytes in Metabolic Syndrome
COMPLETED · NA
-
Novel Therapies for Metabolic Complications of Lipodystrophies
COMPLETED · NA
-
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
COMPLETED · NA
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
COMPLETED · NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
COMPLETED · NA
-
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia